Anaesthetic efficacy of 2% lignocaine without adrenaline in patients with irreversible pulpitis in mandibular molars undergoing vital pulp therapy: A prospective, randomized, double-blind study

Original Research

Abstract

Introduction: This exploratory, prospective, randomised, double-blind clinical investigation's main objective was to assess the effectiveness of pulpotomy treatments for mandibular molars with irreversible pulpitis using 2% lignocaine with and without epinephrine.

Methods: The subjects were split into two groups at random. The Heft Parker Visual Analogue Scale was used to capture the subject's self-reported pain reaction before the study began (pre HP VAS scores). All subjects received a standard IANB along with buccal infiltration of either plain 2% lignocaine (test group) or 2% lignocaine with 1:1000,000 epinephrine (control group). The level of pain was assessed using the HP VAS scale once again following caries excavation and pulp exposure (Post HP VAS Scores), and a full pulpotomy was carried out by amputating the pulp to the canal orifices level. Following this haemostasis was attained and MTA (ProRoot; Dentsply, Tulsa, OK, USA) capping done. Temporary restorations were given immediately. Patients were recalled after 2 weeks for a permanent restoration.

Results: The variance analysis (one way ANOVA) and post hoc Tukey LSD statistical investigation revealed a significant distinction in success rates between the two trial groups (p-value = 0.037).

Conclusions: In mandibular molars with irreversible pulpitis receiving critical pulp treatment, IANB and buccal infiltration with 2% lignocaine without epinephrine can be taken into consideration as suitable substitutes for producing pulpal analgesia.